Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Rebecca Panks

  • Home
  • Author: Rebecca Panks

Keystone Heart may experience rocky start despite receiving CE mark amid COVID-19 pandemic, says GlobalData

Amid the ongoing COVID-19 pandemic, Keystone Heart secured CE approval for its cerebral embolic protection device, the TriGUARD3. However, GlobalData expects that the company will experience a rocky start as a result of the pandemic. In March 2020, Keystone Heart announced that its TriGUARD3 device received CE approval. The cerebral embolic protection device is designed […]
Read more

Intensive care units would experience severe strain from high-risk groups of COVID-19, says GlobalData

As the COVID-19 situation grows, intensive care units (ICUs) in hospitals have to handle more patients with severe cases of the virus. COVID-19 can be more severe for those individuals with pre-existing conditions such as diabetes, heart disease, chronic obstructive pulmonary disease (COPD), and asthma along with immune-compromised or older individuals. As Europe and the […]
Read more

WeWork debacle portends a crisis for tech unicorns, says GlobalData

Last week, GlobalData predicted SoftBank would turn off WeWork’s funding. Following the announcement that WeWork is taking its biggest investor to court, after SoftBank withdrew a $3bn capital injection; Oliver Lockett, Thematic Analyst at GlobalData, a leading data and analytics company, offers his view on the company’s current challenges: “Many companies will not survive the COVID-19 shakedown. […]
Read more

With fast-food visits down globally by 50%, why does maintaining employee relations matter, asks GlobalData

Frontline workers of essential foodservice operators in the US have received minimal ‘reward schemes’ for attending work amid the COVID-19 outbreak. These companies should be wary of what effects misjudgments like these could mean.Public perception is more relevant in today’s digital age than ever before, and with 50% of global consumers having stopped all visits […]
Read more

COVID-19 leads to unpredictable IPOs and venture financing deals for biopharma companies, says GlobalData

In this unprecedented time of uncertainty, key markets have lost 20–70% of their value year-to-date due to COVID-19, according to GlobalData’s COVID-19 Executive Briefing. Sharon Cartic, Associate Director for Drugs and Business Fundamentals Databases at GlobalData, comments: “This drop in value is inevitably having an impact on the initial public offerings (IPOs) of biopharma companies […]
Read more

FDA’s new EUA guidance will make it easier for more coronavirus tests to enter market, says GlobalData

Following the US Food and Drug Administration’s (FDA’s) release for new emergency use authorization (EUA) guidance for laboratory developed coronavirus tests; Dara Lo, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “The gold standard for diagnosing COVID-19 is a common lab test using the polymerase chain reaction (PCR). While […]
Read more

Cambridge Respiratory Innovations to become vital player in capnography market, says GlobalData

Following news that Cambridge Respiratory Innovations has teamed with several NHS trusts to supply N-Tidal (capnography) devices in order to help doctors identify when to ventilate COVID-19 patients; Aliyah Farouk, Medical Device Analyst at GlobalData, a leading data and analytics company, offers her view: “The accelerated production of N-Tidal devices by Cambridge Respiratory Innovations to […]
Read more

Companies across industries anticipating COVID-19 to take a toll on earnings, says GlobalData

An uncertain business environment on the back of the COVID-19 outbreak is prompting companies to withdraw or revise their guidance, outlook and earnings estimates, according to GlobalData, a leading data and analytics company. Aurojyoti Bose, Lead Analyst at GlobalData, comments: “The outbreak and its potential impact on the economy and businesses is weighing heavily on […]
Read more

COVID-19 social distancing measures will impede global RSV clinical development, says GlobalData

Following the introduction of social distancing measures, brought in to reduce the spread of COVID-19 across the globe; Emily Carter-Richardson, Pharma Analyst at GlobalData, a leading data and analytics company, offers her view on how this could impact the development of respiratory syncytial virus (RSV) vaccines: “The infection control measures of social distancing to prevent […]
Read more

COVID-19 could be point of no return for Big Tech’s war on misinformation, says GlobalData

Following the news that Facebook’s WhatsApp is imposing new limits on message forwarding to tackle the dissemination of fake news; Laura Petrone, Senior Analyst at GlobalData, a leading data and analytics company, offers her view: “Big Tech’s more active role in policing misinformation during the COVID-19 pandemic demonstrates that these companies are taking greater responsibility […]
Read more
1 … 59 60 61 62 63 … 77